'Halftime Report' Traders Share Their Thoughts On Crispr Therapeutics And Bed Bath & Beyond

Amy Raskin said on CNBC's "Fast Money Halftime Report" that she would hold Crispr Therapeutics AG CRSP. She doesn't own the stock, but she owns Intellia Therapeutics Inc NTLA in the space.

Pete Najarian sees Bed Bath & Beyond Inc. BBBY as a trading vehicle because of volatile trading. A lot of that has to do with the short interest of the company.